Norma terapêutica da diabetes mellitus tipo 2

Bibliographic Details
Main Author: Pinto, Daniel
Publication Date: 2011
Other Authors: Heleno, Bruno, Gallego, Rosa, Santos, Isabel, Santiago, Luiz Miguel, Maria, Vasco
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/147361
Summary: Clinical guidelines have the potential to increase health gains, but also to cause harm. In this opinion article we state some misgivings about the application of the Portuguese National Health Directorate's guideline type 2 diabetes therapy: metformin in primary care. We seek to highlight guideline wording that may allow for multiple interpretations (alternatives to monotherapy with metformin, hierarchy of drugs to be associated with metformin, and metformin contraindications). Furthermore, we argue that it seems that choosing a glycemic target of 6.5% in a normative document to be applied in the general population may have unforeseen consequences.
id RCAP_fe465a1ae2a227ce7705532f6084a41b
oai_identifier_str oai:run.unl.pt:10362/147361
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Norma terapêutica da diabetes mellitus tipo 2GuidelineType 2 diabetes mellitus therapy: Metformin: A critical perspectiveMetformina uma perspectiva críticaMedicine(all)SDG 3 - Good Health and Well-beingClinical guidelines have the potential to increase health gains, but also to cause harm. In this opinion article we state some misgivings about the application of the Portuguese National Health Directorate's guideline type 2 diabetes therapy: metformin in primary care. We seek to highlight guideline wording that may allow for multiple interpretations (alternatives to monotherapy with metformin, hierarchy of drugs to be associated with metformin, and metformin contraindications). Furthermore, we argue that it seems that choosing a glycemic target of 6.5% in a normative document to be applied in the general population may have unforeseen consequences.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNPinto, DanielHeleno, BrunoGallego, RosaSantos, IsabelSantiago, Luiz MiguelMaria, Vasco2023-01-11T22:17:36Z2011-032011-03-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article8application/pdfhttp://hdl.handle.net/10362/147361por1646-0758PURE: 47549307info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-22T18:08:00Zoai:run.unl.pt:10362/147361Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:38:28.688364Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Norma terapêutica da diabetes mellitus tipo 2
GuidelineType 2 diabetes mellitus therapy: Metformin: A critical perspective
Metformina uma perspectiva crítica
title Norma terapêutica da diabetes mellitus tipo 2
spellingShingle Norma terapêutica da diabetes mellitus tipo 2
Pinto, Daniel
Medicine(all)
SDG 3 - Good Health and Well-being
title_short Norma terapêutica da diabetes mellitus tipo 2
title_full Norma terapêutica da diabetes mellitus tipo 2
title_fullStr Norma terapêutica da diabetes mellitus tipo 2
title_full_unstemmed Norma terapêutica da diabetes mellitus tipo 2
title_sort Norma terapêutica da diabetes mellitus tipo 2
author Pinto, Daniel
author_facet Pinto, Daniel
Heleno, Bruno
Gallego, Rosa
Santos, Isabel
Santiago, Luiz Miguel
Maria, Vasco
author_role author
author2 Heleno, Bruno
Gallego, Rosa
Santos, Isabel
Santiago, Luiz Miguel
Maria, Vasco
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Pinto, Daniel
Heleno, Bruno
Gallego, Rosa
Santos, Isabel
Santiago, Luiz Miguel
Maria, Vasco
dc.subject.por.fl_str_mv Medicine(all)
SDG 3 - Good Health and Well-being
topic Medicine(all)
SDG 3 - Good Health and Well-being
description Clinical guidelines have the potential to increase health gains, but also to cause harm. In this opinion article we state some misgivings about the application of the Portuguese National Health Directorate's guideline type 2 diabetes therapy: metformin in primary care. We seek to highlight guideline wording that may allow for multiple interpretations (alternatives to monotherapy with metformin, hierarchy of drugs to be associated with metformin, and metformin contraindications). Furthermore, we argue that it seems that choosing a glycemic target of 6.5% in a normative document to be applied in the general population may have unforeseen consequences.
publishDate 2011
dc.date.none.fl_str_mv 2011-03
2011-03-01T00:00:00Z
2023-01-11T22:17:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/147361
url http://hdl.handle.net/10362/147361
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 1646-0758
PURE: 47549307
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 8
application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596854290350080